Alzheimer’s is the most common form of dementia and affects around 850,000 people living in the UK, but a new drug aims to help patients in the early stages.
A “groundbreaking” drug that could slow down Alzheimer’s disease may soon be available to millions.
US pharmaceutical giant Biogen is looking to get approval to make the drug readily available.
Successful medical trials showed significant results for using the drug - known as aducanumab.
Biogen said results from more than 3,000 people with Alzheimer’s showed the drug led to a significant slowing of the disease’s progression.
Analysis of the trial data found that patients using the drug experienced benefits in memory, orientation, language and everyday living skills, such as shopping.
If it's approved, Biogen says the drug would be the first treatment to “reduce the clinical decline” of patients in the early stages - a significant breakthrough in terms of dementia.
Aducanumab is the first of its kind. Currently, there are only drugs that can help with symptoms.
The approval process could take up to two years but if it’s successful, the company hopes to initially offer the drug to the patients enrolled in the clinical studies.
The drug works by targeting a protein called amyloid, which forms abnormal deposits the brains of people with Alzheimer's.
Hilary Evans, from Alzheimer's Research UK, said: "People affected by Alzheimer's have waited a long time for a life-changing new treatment and this exciting announcement offers new hope that one could be in sight.
"Taking another look at aducanumab is a positive step for all those who took part in the clinical trials and the worldwide dementia research community.
"As more data emerges, we hope it will spark global discussions about the next steps for delivering much-needed treatments into people's hands."
The news comes as a slight surprise, due to the fact that Biogen stopped two studies of the drug earlier this year. This is because partial results suggested it was not likely to be successful.
Biogen have since said the findings of the initial analysis were "incorrect".
-
-
Meghan Markle has decided not to have a baby shower for this reason
No lavish celebrations this time around
By Danielle Valente •
-
Alex Rodriguez speaks out for the first time since J.Lo and Ben Affleck reunion
News of Jennifer Lopez and Ben Affleck has spread, and now Alex Rodriguez is finally saying something
By Rylee Johnston •
-
This TikTok ab dance is going viral—but you should know this before you try it
Read before attempting!
By Danielle Valente •
-
The best sleep apps to tackle common sleep problems and help you drift off easier
These apps track and monitor your sleep, to have you snoozing in no time!
By Ciara McGinley •
-
The best sleep guided meditations for drifting off at night
Try sleep guided meditations to help you fall asleep and snooze through the night
By Ciara McGinley •
-
Fitness for women over 50–five workouts to kickstart your fitness journey
Plus, experts share how these activities will transform your physical fitness and emotional wellbeing
By Ciara McGinley •
-
The best workouts for getting fit and feeling good
Get moving with five of the best workouts for women
By Faye M Smith •
-
Why strength training is so important for women and how to do it at home
Whether it’s using bodyweight or dumbbells, strength training for women could make all the difference to body and mind
By Lucy Gornall •
-
The best at-home workouts for every fitness goal
From the time-poor to the early risers, we've got you covered with the best at-home workouts
By Ciara McGinley •
-
MASKC's colorful KN95 face masks are a hit with A-listers—and they're currently on sale!
Celebrities are loving this MASKC KN95 mask that comes in a range of chic colours and patterns
By Laura Harman •
